Arkolith/Insider Trading/ELDN/Form 4

BVF Inc

10% OwnerEledon Pharmaceuticals, Inc. (ELDN) · full profile →Form 4 · filed May 13, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 9, 2024Buy(P)1.0M——3.4M
May 9, 2024Buy(P)821K——2.6M
May 9, 2024Buy(P)75K——220K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 9, 2024Buy(P)232K——232K
May 9, 2024Buy(P)3.2M——3.2M
May 9, 2024Buy(P)2.5M——2.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-24-001131) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML